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To define the current indications for surgical management of pleuropul- 
monary tuberculosis and analyze the results of operative procedures, the 
records of 59 patients operated on between January 1987 and December 
1993 were reviewed. Three patient categories were defined. Group I patients 
(n = 25) underwent operation for diagnostic purposes: solitary mediastinal 
node or mediastinal adenopathy associated with pulmonary lesions (n = 
10), pulmonary infiltrates (n = 4), pulmonary nodules or masses (n = 10), 
or chronic pleurisy (n = 1). Postoperative mortality and morbidity rates in 
this group were both 4%. Group II patients (n = 18) underwent operation 
for active lesions: intrapulmonary cavity (n = 6), destroyed lung paren- 
chyma (n = 6), or chronic loculated pleural effusion (n = 6). Postoperative 
morbidity and mortality rates were 16.6% and 5.5%, respectively. Group III 
patients (n = 16) underwent operation for a complication of therapy or for 
sequelae of previously "cured" tuberculosis: calcified pyothorax (n = 8), 
empyema (n = 2), fistulized nodes (n = 2), bronchiectasis (n = 3), or 
aspergilloma (n = 1). Morbidity and mortality rates in this group were 
31.25% and 12.5%, respectively. Surgery continues to have both diagnostic 
and therapeutic indications for management of pleuropulmonary tubercu- 
losis, despite the morbidity and mortality rates associated with operative 
procedures. (J TrlORAC CARDIOVASC SURG 1996;111:662-70) 
S ince the introduction of antitubercular drugs, the surgical procedures historically performed to 
cure tuberculosis, ranging from artificial pneumo- 
thorax to thoracoplasty, have been relegated to the 
secondary role of palliating the insufficiencies of med- 
ical therapy. In our geographic area, however, demo- 
graphics are such that we are treating surgically both 
elderly patients with therapeutic sequelae of tubercu- 
lous lesions and increasing numbers of tuberculous 
patients coinfected with the human immunodeficiency 
virus (HIV). This study was performed to determine 
the current indications for and results of surgical 
management of pleuropulmonary tuberculosis. 
Patients and methods 
This retrospective chart review covered 59 patients (35 
men and 24 women) with a mean age of 56 years (range 17 
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to 82 years) operated on between January 1987 and Decem- 
ber 1993 for active tuberculosis or complications of tubercu- 
losis (Table I). Only patients with lesions caused by Myco- 
bacterium tuberculosis were included. Patients were 
subdivided into three categories. Group I consisted of 25 
patients for whom surgical intervention had a diagnostic 
purpose; diagnosis of tuberculosis was confirmed by his- 
topathologic demonstration f caseous necrosis or bacterio- 
logic examination (smears or cultures) demonstrating M.
tuberculosis. Group II patients (n = 18) underwent opera- 
tions for active tuberculous lesions during the course of 
medical therapy. Group III consisted of 16 patients who 
underwent operation for complications related to inactive, 
previously "cured" tuberculosis. Records were reviewed for 
age, sex, ethnic origin, HIV serologic results, history, clinical 
symptoms, lesions, surgical procedures, and postoperative 
events. The long-term outcome after operation was deter- 
mined from records of follow-up visits at our institution or 
data provided by the patient's private physician. Two pa- 
tients were unavailable for follow-up. The outcomes of the 
57 other patients are known, with a minimum follow-up 
period of 6 months (range 6 to 84 months). 
Results 
Group I. The 25 patients in group I (14 men and 
11 women) had a mean age of 56.8 years (range 17 
to 80 years). Ten patients were immigrants (from 
northern Africa and southeast Asia). Six patients 
were HIV-seropositive and 10 others had various 
The JournN of Thoracic and 
Cardiovascular Surgery 
Volume 111, Number 3 
Mouroux et al. 6 6 3 
Table I. Clinical summary 
Number of 
patients Presentmg features Lesions Procedures Deaths Complications 
Group I 
10 
4 
10 
1 
Group II 
6 Empyema (5); with Chronic loculated pleural 
subcutaneous abscess (1) effusion (6) 
2 Hemoptysis Lesions in 1 lobe (1); 
in 1 lung (1) 
5 MT-positive (5) Cavitary lesion 
5 MT-positive (4); worsening Destroyed lung 
clinical status 
Group III 
8 Infection Calcified pyothorax 
1 
Total 
59 
Asthenia (3); fever (3); Adenopathies: mediastinal (8); Mediastinoscopy (9); 0 0 
cervical swelling (1); cervicomediastinal (1), with cervicotomy (1) (biopsies) 
radiologic findings (4) upper lobe infiltrates (1) 
Dyspnea (3); radiologic Interstitial pneumonitis Lung biopsies 1 0 
findings (1) 
Radiologic findings (4); Nodule (7); cavitary nodule (3) Lobectomy (6); wedge 0 1 (pneumonia) 
asthenia (2); fever (2); resection (4) 
chest pain (2); 
hemoptysis (2) 
Chest pain, asthenia Chronic pleural effusion Pleural and lung biopsies 0 0 
0 
0 
0 
1 
Decortication (5); 
drainage (1) 
Lobectomy (1); 
pneumonectomy (1)
Lobectomy (5) 
Pneumonectomy (3); 
pleuropneumonectomy (2) 
1 (prolonged 
air leak) 
2 (hemorrhage, 
phlebitis) 
Decortication (5); 0 5 (3 prolonged 
Pleuropneumonectomy (2); air leak; 
Pleurolobectomy (1) 1 empyema; 
1 acute lung 
edema) 
Infection Empyema Drainage-irrigation (2); 1 0 
+ thoracostomy (1) 
Hemoptysis Fistulized adenopathies Nodal excision 0 0 
Recurrent infections (3); Bronchiectasis Lobectomy (2); 1 0 
hemoptysis (3) pneumonectomy (1)
Hemoptysis Aspergilloma Lobectorny (1) 0 0 
4 (6.7%) 9 (15.25% 
MT, ~1~ tuberculosis. 
risk factors for active tuberculosis: smoking (n = 4), 
kidney transplantation (n = 1), diabetes (n = 1), 
obstructive bronchopulmonary disease (n = 2), or 
cancer (n = 2). Tuberculosis was suspected in nine 
patients (36%), but results of routine diagnostic 
procedures (search for M. tuberculosis in sputum 
samples or bronchial washings, transbronchial bi- 
opsy) were negative. In nine cases (36%), operation 
was prompted by suspicion of a primary or second- 
ary malignancy. No presumptive diagnosis was made 
in the other cases. 
Ten patients (including four who were seroposi- 
tive for HIV) had mediastinal or cervicomediastinal 
adenopathy, either a solitary node (n = 9) or nodes 
associated with an upper pulmonary lobe infiltrate 
(n = 1). These patients underwent nodal biopsy by 
mediastinoscopy (n = 9) or cervicotomy (n = 1). 
Four patients (including two who were seropositive 
for HIV) had a diffuse pulmonary infiltrate; lung 
biopsies were performed by thoracotomy (n = 2) or 
video-assisted thoracoscopy (n = 2). Ten patients 
had nodules or parenchymal masses, including three 
cavitary lesions. Five of these 10 patients had previ- 
ously undergone noncontributory computed tomog- 
raphy--guided percutaneous needle aspiration. 
Treatment consisted of wedge resection or lobec- 
tomy, depending on lesion site and diameter; surgi- 
cal resection was performed by thoracotomy (n = 8) 
or video-assisted thoracoscopy (n = 2). One patient 
with chronic pleurisy underwent video-assisted tho- 
racoscopic lung and pleural biopsy. 
Mortality and morbidity rates in this group were 
both 4%. The only death occurred in a 78-year-old 
patient who underwent lung biopsy by thoracotomy 
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after admission for acute febrile respiratory failure. 
Deterioration of his condition, despite administra- 
tion of nonspecific antibiotic therapy and negative 
results of bacteriologic cultures, prompted surgical 
biopsy, which established a diagnosis of miliary 
tuberculosis. Death occurred from respiratory fail- 
ure refractory to therapy postoperative day 10. 
The nonimmunodepressed patients in the remain- 
ing group of 24 survivors were placed on the classic 
6-month treatment regimen used in France; this 
protocol consists of a four-drug regimen (rifampin, 
isoniazid, ethambutol, and pyrazinamide) for 2 
months, followed by a two-drug regimen (rifampin 
and isoniazid) for 4 months. The HIV-seropositive 
patients in this group were treated for 9 months 
(four drugs for 3 months and then two drugs for 6 
months). The outcome was favorable for all 24 
patients, regardless of immune status. Three HIV- 
seropositive patients died 18, 36, and 50 months 
after diagnosis of tuberculosis, but these deaths 
were not caused by disease reactivation. 
Group II. Group II consisted of 18 patients (11 
men and 7 women) with a mean age of 47.5 years 
(range 23 to 80 years). Seven were immigrants (from 
northern Africa and Romania) and seven had risk 
factors for active tuberculosis: alcoholism and smok- 
ing (n = 5) or obstructive bronchopulmonary dis- 
ease (n = 2). The initial treatment and follow-up of 
these patients were managed by our institution's 
Pneumology Department. None of these patients 
had ever had a strain of M. tuberculosis resistant to 
the antitubercular d ugs used. 
Eight patients required operation for a complica- 
tion during medical therapy that had been followed 
correctly for 1 to 6 months; four were on a four-drug 
regimen (rifampin, isoniazid, ethambutol, and pyra- 
zinamide) and the other four were on a two-drug 
regimen (rifampin and isoniazid). Five patients with 
empyema were treated by pleural decortication. 
One patient had a pleuroparietal cold abscess; the 
lesion was opened and the pleural cavity was treated 
by drainage and irrigation. Repeated episodes of 
hemoptysis in two patients necessitated lobectomy 
(n = 1) or pneumonectomy (n = 1). 
Ten patients underwent operation because of the 
inefficacy of medical management. Five of these had 
a tuberculous cavity in a single lobe; direct sputum 
smears demonstrated M. tuberculosis in all cases, 
despite apparent compliance with treatment (four- 
drug regimen) for 3 to 7 months. All five patients 
underwent lobectomy. After operation, a prolonged 
air leak (14 days) without any demonstrable bron- 
chial fistulas developed in one patient. Histopatho- 
logic examination of the surgical specimens demon- 
strated active tubercular lesions in all cases. One 
patient had coexistent adenocarcinoma. Five pa- 
tients had diffuse lesions in a single lung, corre- 
sponding to destroyed lung parenchyma; two had 
complied with the four-drug regimen for 3 and 6 
months. The other three patients, who had been 
treated for 8, 12, and 15 months, admitted having 
taken their treatment only sporadically. All five 
patients had a deterioration in general condition, 
with loss of 5% to 20% of initial weight; two patients 
had several bouts of hemoptysis. Direct sputum 
smears showed M. tuberculosis for four patients. 
Procedures consisted of pneumonectomy (n = 3) 
and, for the two patients whose disease had been 
active for 12 and 15 months, extrapleural pneumo- 
nectomy. A 75-year-old patient reated by extrapleu- 
ral pneumonectomy died on postoperative day 5 of 
multiple organ failure; another patient had hemor- 
rhage in the chest cavity necessitating thoracotomy 
for clot evacuation. One patient had lower limb 
phlebitis, which had a favorable outcome. His- 
topathologic examination of the resected specimens 
revealed active tubercular lesions, bronchial dilata- 
tion, and scleroemphysema of varying severity. 
Overall mortality and morbidity rates in Group II 
were 5.5% and 16.6%, respectively. Regardless of 
the indication for operation, all survivors were dis- 
charged after operation on a four-drug regimen. 
The decision to switch to a two-drug regimen, which 
was based on clinical status or negative results of 
sputum examinations, was made between postoper- 
ative months 3 and 6. The total duration of treat- 
ment varied from 9 to 12 months. Two patients died 
of unrelated causes 12 and 32 months after opera- 
tion; the others have had favorable outcomes re- 
gardless of ethnic origin. 
Group III. The 16 patients in group III (10 men 
and 6 women) had a mean age of 65 years (range 44 
to 82 years). Two patients had diabetes, one had 
adrenal insufficiency, and two had alcoholism and 
smoked. 
Eight of these 16 patients had a calcified pyotho- 
rax after artificial pneumothorax (n = 6) performed 
a mean of 32 years earlier (range 23 to 44 years) or 
tuberculous pleurisy (n = 2) treated 12 and 24 years 
previously. Operation was prompted by recurrent 
infections. Five patients underwent drainage-irriga- 
tion of the cavity (duration 8 to 19 days) before 
operation. Bacteriologic cultures grew M. tuberculo- 
sis (n = 1), Staphylococcus aureus (n = 3), Es- 
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cherichia coli (n = 1), or Streptococcus species (n = 
1). One patient had multiple organisms (Streptococ- 
cus species, Bacteroides fragilis, Enterobacter cloa- 
cae). The procedures consisted of decortication 
(n = 5), pleuropneumonectomy (n = 2), or pleu- 
rolobectomy (n = 1). After operation, three patients 
had a prolonged air leak (10 to 21 days after 
decortication); one patient had a pyothorax after 
extrapleural pneumonectomy without fistulization, 
which was successfully treated by drainage-irriga- 
tion; another patient had acute lung edema, which 
resolved with treatment. 
Two patients had empyema fter pneumonec- 
tomy performed 27 years earlier for tuberculosis; 
neither had a bronchopleural fistula. Infection of the 
pneumonectomy cavity in one patient was caused by 
S. aureus; treatment consisted of drainage-irrigation 
and appropriate antibiotics. This patient had a fa- 
vorable course. The second patient had an infection 
of the pneumonectomy cavity caused by M. tubercu- 
losis; specific antibiotics and drainage-irrigation 
failed to sterilize the cavity and thoracostomy 
proved necessary. Despite a favorable local course, 
this patient had a severe depressive syndrome and 
committed suicide after 45 days of treatment. 
Three patients who had been treated for tubercu- 
losis 14, 15, and 18 years earlier had bronchiectasis 
involving the upper right lobe (n = 1), the middle 
lobe (n = 1), or the right lung (n = 1). The 
indication for operation was recurrent infections, 
which were always associated with hemoptysis. One 
of these patients, who was treated by pneumonec- 
tomy, died on postoperative day 4 of a pulmonary 
embolus. 
Two patients who had been treated for tubercu- 
losis 3 and 5 years earlier had calcified adenopathy 
with bronchial fistulization, which manifested as 
episodes of hemoptysis. Fiberoptic bronchoscopy 
visualized a calcified node in a fistulous orifice in 
both cases (2 and 3 mm diameter fistulas, at the 
origin of the right superior lobar bronchus and on 
the intermediate bronchus). Surgical intervention 
consisted of resection of the node and suture of the 
communication. 
Three years after therapy for tuberculosis, one 
patient had an aspergilloma in a sterilized cavity 
(free of M. tuberculosis) in the upper left lobe; this 
lesion was responsible for hemoptysis. Treatment 
consisted of lobectomy. 
After operation, a classic antituberculosis regi- 
men (four-drug then two-drug regimen) was pre- 
scribed for 6 months for the seven patients in whom 
M. tuberculosis was identified as well as for those 
patients who had never received a complete antitu- 
berculosis treatment at the time of initial diagnosis. 
The other patients were treated empirically with a 
two-drug regimen for 4 months. 
Three deaths occurred at long term; two patients 
died of unrelated causes 24 and 48 months after 
operation. The third patient had undergone ex- 
trapleural pneumonectomy, but complete removal 
of the calcified capsule had proved impossible. 
Despite successful management of a recurrent in- 
fection of the cavity 6 months later by drainage- 
irrigation, shortly thereafter a new infection was 
responsible for the patient's death. 
Discussion 
Historically, surgery has played a major role in the 
treatment of pleuropulmonary tuberculosis. During 
the first half of this century, anumber of techniques 
were developed for collapse therapy, ranging from 
intrapleural pneumothorax to thoracoplasty. Treat- 
ment was designed to allow the tuberculous lesions 
to rest by eliminating the elastic forces of the lung 
that kept the cavities open. A stay at a sanatorium 
complemented these procedures. In 1944, the dis- 
covery of streptomycin modified the therapeutic 
protocol while leaving a place for collapse therapy 
and surgical resection. Starting in the 1960s, ri- 
fampin and other antitubercular drugs radically 
transformed the prognosis of the disease, and sur- 
gery was relegated to a secondary role for the 
treatment of complications. 
The increasing incidence of acquired immunode- 
ficiency syndrome and its recognized association 
with the resurgence of tuberculosis underscores the 
need for young surgeons to remain aware of the 
surgical techniques for management of tuberculosis 
and its sequelae. 14 To determine the current role of 
surgery, procedures performed for diagnostic pur- 
poses (group I, 25 patients, 42.4%) were analyzed 
separately from therapeutic procedures for active 
lesions (group II, 18 patients, 30.5%) or complica- 
tions (group III, 16 patients, 27.1%). 
Diagnostic surgical procedures continue to play 
an important role, despite modern diagnostic tech- 
niques. As in the past, operation is indicated for 
potentially neoplastic lesions (pulmonary masses or 
nodules),5, 6 which accounted for 36% of the cases in 
group I. As emphasized by other authors, percuta- 
neous needle aspiration appears to be of limited 
value in these cases .  6 Our series was particular in 
that operations were also performed for lesions with 
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unusual radiologic and clinical characteristics ( oli- 
tary adenopathy, interstitial pneumonitis) for which 
a diagnosis of tuberculosis  not always entertained. 
These atypical clinical esions, first reported some 10 
years ago, 3 are observed especially in HIV-seropos- 
itive patients at an advanced stage of disease (CD4 
<200 cells/ram3). 7'8 The particular clinical and ra- 
diologic features become increasingly atypical: 
equal frequency of distribution between the upper 
and lower lobes, lack of excavation, mediastinal 
adenopathy (solitary or multiple nodes), associated 
pleural effusions, and high frequency of extrapulmo- 
nary dissemination. TM 
Diagnostic interventions include biopsy (nodal, 
pulmonary, or pleural) and resection. Mediastinos- 
copy is the most commonly used method (nine 
cases) for biopsy of mediastinal nodes. Lung and 
pleural esions are often amenable to video-assisted 
thoracoscopy, a recent echnique that we have used 
on five occasions ince 1991. Less aggressive than 
thoracotomy, and thus more easily accepted by 
patients, video-assisted thoracoscopy is particularly 
suitable for lung or pleural biopsies because the only 
potential difficulty is a dense symphysis, which can 
interfere with or prevent successful examina- 
tion. 12-14 In patients with nodular lesions, video- 
assisted thoracoscopy is reserved for peripheral 
nodes at least 3 cm in diameter, which can usually be 
managed by wedge resection. By contrast, for cen- 
tral and especially large lesions, which generally 
require lobectomy, we still prefer thoracotomy. Ex- 
temporaneous examination always remains indis- 
pensable to rule out an associated neoplasm (one 
case in our series). The cost effectiveness of these 
diagnostic procedures and the current possibilities 
of video-assisted thoracoscopy should help elimi- 
nate diagnostic delays. 
Although surgery is theoretically of limited value 
in cases of active disease, it was indicated in two 
circumstances in our study: (1) treatment of a 
complication is despite compliance with medical 
treatment (persistent or recurrent hemoptysis [two 
cases], empyema [five cases], or cold abscess [one 
case]) or (2) no response to medical therapy (10 
cases). 
Infections in some certain patients demonstrate 
true primary resistance to classically used antibiot- 
ics. This situation has been reported in certain urban 
areas of the United States. A 1991 study in New 
York City, for example, mentioned a primary resis- 
tance rate of 23%. In that study, 33% of the 466 
strains tested were resistant o at least One antitu- 
bercular drug, and 19% were resistant to isoniazid 
and rifampin. 16 
Multidrug resistance is favored by a number of 
factors, including poorly conducted previous ther- 
apy, coinfection with HIV, and intravenous use of 
illicit drugs. In these situations, Iseman and col- 
leagues ~7 demonstrated the complementary role of 
surgery in selected patients. In their study, 29 of 99 
patients with drug-resistant disease were selected 
for surgical treatment, and 25 of the 27 survivors had 
a favorable course with negative results of sputum 
examinations after treatment. ~7 
The current situation in France is somewhat 
different, because primary resistance rates during 
the same period as the study by Iseman and col- 
leagues were only 6% for streptomycin, 2% for 
isoniazid, and less than 1% for rifampin, ethambu- 
tol, and pyrazinamide. 18 Our experience differs from 
that of these U.S. authors because we never encoun- 
tered any M. tuberculosis strain resistant to the drugs 
used during follow-up of our patients. 
In our series, operations were performed in two 
situations: (1) persistent M. tuberculosis on direct 
sputum examination after at least 3 months of a 
4-drug regimen (drug efficacy was verified by sus- 
ceptibility testing) or (2) clinical and radiologic 
demonstration of progressive disease. These cases 
can be explained by two mechanisms: existence of 
specific focal or diffuse lesions (tuberculoma or 
cavities) acting as reservoirs for the tubercle bacilli 
where diffusion of antibiotics i poor (seven patients; 
Fig. 1) or poor therapeutic compliance with inter- 
ruption of or intermittent drug intake (3 patients). 
In these situations, as in cases of true drug resistance 
as reported by Iseman and colleagues 17resection of 
major lesions can favor the action of the antibiotics 
on other disease sites. 19 After operation, treatment 
was continued in our patients for 9 to 12 months; 
continuation for 18 to 24 months is advisable in case 
of true drug resistance. 17Our results, like those of 
Iseman and colleagues, 17clearly demonstrate the 
complementary role of surgery in the treatment of 
patients with resistant disease. 
The most common procedures for active lesions 
involve parenchymal resection (segmentectomy, lo- 
bectomy, or pneumonectomy). Of the various "clas- 
sic" interventions ( pe!eotomy, phrenic nerve crush, 
thoracoplasty), only thoracoplasty retains a role as a 
complement to resection or decortication. 2° Be- 
cause of the complementary nature of resection for 
treatment of tuberculosis, the procedure must be 
adapted (1) to the location and extent of major 
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Fig. 1. A 35-year-old prison inmate with persistent M. tuberculos& in sputum despite 3 months f t erapy. 
The computed tomographic chest scan revealed a cavity, which w s managed by lobectomy, in the upper 
left lobe. 
lesions (this is best evaluated by computed tomo- 
graphic scans), (2) to the patient's ventilatory re- 
serve, and (3) to the functional value of the paren- 
chyma scheduled for resection, as determined by 
ventilation and perfusion radionuclide lung scans. In 
our series, we were able to limit resection to lobec- 
tomy in six cases. In five patients, the extent of 
lesions necessitated pneumonectomy; two patients 
whose disease had been active for longer than a year 
had extensive pleuropulmonary adhesions that led 
to extrapleural pneumonectomy. The postoperative 
courses of these patients (one death, one hemor- 
rhage) reflect the severity of these procedures, 
which in our opinion should be considered only 
when absolutely necessary. A number of technical 
issues merit discussion. (1) Selective tracheobron- 
chial intubation and ventilatory exclusion before the 
patient is placed in the lateral decubitus position 
reduces the risk of contamination of the contralat- 
eral lung. (2) Pedicular dissection can be compli- 
cated by the existence of large inflammatory nodes 
and must be performed prudently. Reed, Parker, 
and Crawford 15 reported a case of laceration of the 
right pulmonary artery during an upper lobectomy. 
(3) In case of severe infection, certain authors 
report covering the suture with a muscle flap to 
reduce the risk of fistulization, 17 but we have never 
used this technique. (4) Because of the possibility of 
insufficient reexpansion of the residual ung paren- 
chyma after lobectomy, thoracoplasty has been pro- 
posed during the same operative session. 21 Al- 
though we agree that such an approach may be 
indicated when there is a large difference in volume 
between the pleural cavity and the residual paren- 
chyma, in other situations it is better to let the 
residual tissues expand after operation, if neceSsary 
with the help of physical therapy and pneumoperi- 
toneum. If thoracoplasty still proves necessary after 
4 to 8 weeks, it is easier to determine the exact 
extent needed, 2° 
Our last group of patients all had complications of
tuberculosis or previous therapy. Although such 
sequelae generally remain clinically silent and re- 
quire only surveillance and occasionally medical 
therapy, operation is necessary for infectious or 
hemorrhagic complications. A number of the com- 
plications treated surgically in this group have been 
reported frequently in other studies 5'6, 15: empyema, 
bronchiectasis, adenopathy with fistulization, and 
parenchymal cavity with aspergilloma (Fig. 2). Our 
series is notable because of the relatively elevated 
number of patients with infected calcified pleural 
cavities caused by therapeutic pneumothorax (one 
third of the patients in group III, 10% of the series; 
Fig. 3). This can be partially explained by the fact 
that therapeutic pneumothorax was used in France 
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Fig. 2. This 52-year-old patient who had been treated 3 years earlier for tuberculosis had recurrent 
hemoptysis. The computed tomographic chest scan demonstrated an aspergilloma in a sterilized cavity 
(sterilized by treatment) that was treated by lobectomy. 
until fairly recently (one patient in this series under- 
went pneumothorax in 1965). In addition, our re- 
gion is home to numerous elderly persons. This type 
of sequela, like those associated with pleurisy (two 
cases), can arise through infection by the subjacent 
parenchyma (bronchopleural fistula) or less often 
through hematogenous spread from an extratho- 
racic lesion. 22' 23 The causative organisms are usu- 
ally nonspecific (S. aureus was cultured in three of 
seven patients in this series), but M. tuberculosis is 
also encountered (one patient). 
The radiologic and clinical manifestations are 
variable: persistent, long-term fever, progressive de- 
terioration of general condition, and modification of 
the radiologic appearance of pleural sequelae (in- 
crease in size, presence of an air-fluid level). Patient 
age and loss of respiratory capacity as a result of 
previous therapy explain why operation is indicated 
only as a last resort. Nevertheless operation remains 
the only radically effective treatment method. Pre- 
operative workup must guide selection of the 
method best suited to the patient's condition and 
pleuropulmonary lesions. Computed tomography is 
a valuable complement to routine examinations 
such as fiberoptic bronchoscopy, spirometry, and 
radionuclide studies. This imaging technique can 
evaluate the dimensions of the pleural cavity, allow 
prediction of any operative difficulties, and demon- 
strate the extent and the quality of the subjacent 
parenchyma before Operation, local preparation of 
the purulent cavity by drainage-irrigation should be 
performed to reduce the risks of postoperative 
suppuration (this was performed for five patients in 
our series). During this period, patients benefit from 
appropriate antibiotics, respiratory preparation, and 
(eventually) nutritional support. The ideal surgical 
treatment of these pleural cavities remains decorti- 
cation, sometimes associated with limited resection 
(performed in six patients in our series); authors 
with considerable experience with this surgical tech- 
nique have reported good results. 23-25 Extrapleural 
pneumonectomy is sometimes required to resect he 
pleural cavity and the subjacent destroyed lung 
parenchyma (two cases in our series). The risks of 
these procedures, discussed in connection with the 
treatment of active lesions, should limit their use to 
certain carefully selected cases. 23'26 When these 
radical methods are not feasible because of patient 
age, general condition, or functional status, percu- 
taneous drainage (sometimes definitive), thoracos- 
tomy, or various techniques of collapse therapy may 
be attempted. 27-3° 
All of the patients in group III were given antitu- 
bercular drugs after operation, even though we are 
unaware of any study validating this approach other 
than for those who have positive results of M. 
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Fig. 3. This 70-year-old patient reated by pneumothorax for tuberculosis n 1955 had recurrent infections. 
The calcified pyothorax, which contained scattered, bubblelike gas density images visualized by computed 
tomographic chest scans, was successfully treated by decortication. 
tuberculosis testing. The bel ief  that surgical manip-  
ulations and associated t rauma may reactivate foci 
of bacil l i  was the rat ionale for this decision. 
Overall,  our results are less favorable than those 
of other recent series, in which mortal i ty was nil. 6' 15 
Iseman and col leagues 17 reported two deaths among 
their 29 patients, but these deaths were not related 
to operat ion or tuberculosis. When diagnostic pro- 
cedures are analyzed separately, however, the mor- 
tality rate in our series (4%) concurs with l i terature 
dataS, 6,15; the death in this group was directly 
attr ibutable to the severity of the pat ient 's  initial 
condit ion rather than to the surgical procedure.  In 
contrast, our results with surgical management  of 
active lesions (mortal i ty rate of 5.5% and morbidity 
rate of 12.5%) and complicat ions (mortal i ty rate of 
12.5% and morbidity rate of 31.2%) appear  to be 
directly re lated to both the pat ient 's  condit ion and 
the extent of the intervention. Surgical t reatment 
continues to involve considerable risks for this pop- 
ulation, and radical interventions such as extrapleu- 
ral pneumonectomy should be reserved for a highly 
select group of patients in cases of strict necessity. 
We thank Nancy Rameau for assistance with transla- 
tion. 
REFERENCES 
1. Molinard M, Hirsch A, Chrdtien J. La tuberculose: une 
nouvelle priorit6. Presse Med 1994;23:1166-71. 
2. Groupe d'etude t de traitement des infechones fi myco- 
bacteries r6sistantes. Augmentation des cas de tuberculose 
darts trois h6pitaux parisiens [Letter]. Presse Med 1988; 
17:1859. 
3. Langlade LA, Meissner M, Nolan C, Ashbaugh DG. Tuber- 
culosis and the surgeon. Am J Surg 1992,163:505-9. 
4. Theuer CP. Tuberculosis n patients with human immunode- 
ficiency virus infection: review of current concepts. West J 
Med 1989;150:700-4. 
5. Neptune WB, Kim S, Bookwalter J. Current surgical man- 
agement of pulmonary tuberculosis. J THOP, AC CARDIOVASC 
SURG 1970;60:384-91. 
6. Whyte RI, Deegan SP, Kaplan DK, Evans CC, Donnelly RJ. 
Recent surgical experience for pulmonary tuberculosis. Re- 
spit Med 1989;83:357-62. 
7. Meduri UG, Stein DS. Pulmonary manifestations of acquired 
immunodefiency syndrome. Clin Infect Dis 1992;14:98-113. 
8. Murray JF, Mills J. Pulmonary infectious complications of 
human immunodeficiency virus infection. Am RevRespir Dis 
1990;141:1356-72. 
9. Perronne C, Zharaoui M, Leport C, et al. Tuberculose chez 
les malades infect6s par le virus de l'immunoddficience 
humaine: trente observations. Presse Med 1988;17:1479-83. 
10. Long R, Maycher B, Scalani, et al. The chest roentgenogram 
in pulmonary tuberculosis patients seropositive for HIV type 
1. Chest 1991;99:123-7. 
11. Mouroux J, Riquet M, Rotomondo C, et al. In: Champault G, 
Bourgeon A, eds. SIDA et chirurgie. Paris: Springer-Verlag, 
1993:43-58. 
12. Mouroux J, Maalouf J, Bernard JL, et al. Chirurgie thora- 
cique vid6o-assist6e: indications et limites. Ann Chir 1994; 
48:37-42. 
13. Ferson PF, Landreneau RJ, DoMing RD, et al. Comparison 
of open versus thoracoscopic lung biopsy for diffuse infiltra- 
6 7 0 Mouroux et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
March 1996 
tive pulmonary disease. J THORAC CARDIOVASC SURG 1993; 
106:194-9. 
14. Landreneau RJ, Hazelrigg SR, Ferson PF, et al. Thoraco- 
scopic resection of 85 pulmonary lesions. Ann Thorac Surg 
1992;54:415-20. 
15. Reed CE, Parker EF, Crawford FA Jr. Surgical resection for 
complications of pulmonary tuberculosis. Ann Thorac Surg 
1989;48:165-7. 
16. Freden TR, Sterling T, Mendez AP, Jilburn JO, Cauthen 
GM, Dooley SW. The emergence of drug-resistant tubercu- 
losis in New York City. N Engl J Med 1993;328:521-6. 
17. Iseman MD, Madsen L, Goble M, Pomerantz M. Surgical 
intervention i the treatment of pulmonary disease caused by 
drug-resistant Mycobacterium tuberculosis. Am Rev Respir 
Dis 1990;141:623-5. 
18. Bicart-See A, Marchou B. Tuberculose: une lemon d'humilit6. 
Lett Infectiol 1993;8:589-92. 
19. Delarue NC, Gale G. Surgical salvage in pulmonary tuber- 
culosis. Ann Thorac Surg 1974;18:38-51. 
20. Hopkins RA, Ungerleider RM, Staub EW, Young WG. The 
modern use of thoracoplasty. Ann Thor Surg 1985;40:181-7. 
21. Megevand RP, Cherkaoui O, Wipf R, Stinghe R. La 
thoraeoplastie ost6oplastique de Bj6rk. Compl6ment 
th6rapeutique des r6sections pulmonaires partielles: a 
propos de 34 interventions. Ann Chir Thorac Cardiovasc 
1977;16:444-8. 
22. Neff TA, Buchanan BD. Tension pleural effusion: a delayed 
complication of pneumothorax therapy in tuberculosis. Am 
Rev Respir Dis 1975;111:543-8. 
23. Langston HT, Barker WL, Graham AA. Pleural tuberculosis. J 
THORAC CARDIOVASC SURG 1967;54:511-9. 
24. Toty L, Hertzog P, Personne C. R6sultats du traitement 
chirurgical des pyothorax calcifi6s. Rev Tuberc Pneumol 
1969;7:905-30. 
25. Merlier M, Lebrigand H, Rojas-Miranda A, Levasseur P, 
Luizy J. 83 cas de calcifications pleurales. Rev Tuberc 
Pneumol 1969;7:895-904. 
26. Riquet M, Dupont P, Saab M, Debesse B. Poche pleurale 
calcifi6e suppur6e sur poumon d6truit: apropos de 3 obser- 
vations. Rev Gdriatrie 1991;16:313-7. 
27. Iioka S, Sawamura K, Mori T, et al. Surgical treatment of 
chronic empyema: a new one-stage operation. J TnORAC 
CARDIOVASC SURG 1985;90:179-85. 
28. Yuste MG, Ramos G, Duque JL, Gonzalez Selma ML, 
Castanedo M. La thoracopleuromyoplastie comme correc- 
tion d6finitive des empy~mes pleuraux chroniques, apr6s 
pr6paration avec thoracostomie ouverte [English abstract]. 
Ann Chir 1991;45:711-4. 
29. Pairolero PC, Trastek PC. Surgical management of chronic 
empyema: the role of thoracoplasty. Ann Thorac Surg 1990; 
50:689-90. 
30. Pairolero PC, Arnold PG, Pieher JM, McGoon DC. Intratho- 
racic tranposition of extrathoracic skeletal muscle. J THORAC 
CARDIOVASC aURa 1983;86:809-17. 
